Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 8215022)

1.

The biological role of truncated insulin-like growth factor-1 and the tripeptide GPE in the central nervous system.

Sara VR, Carlsson-Skwirut C, Drakenberg K, Giacobini MB, Håkansson L, Mirmiran M, Nordberg A, Olson L, Reinecke M, Ståhlbom PA, et al.

Ann N Y Acad Sci. 1993 Aug 27;692:183-91. Review. No abstract available.

PMID:
8215022
3.

Effects of IGF-1, truncated IGF-1 and the tripeptide Gly-Pro-Glu on acetylcholine release from parietal cortex of rat brain.

Nilsson-Håkansson L, Civalero I, Zhang X, Carlsson-Skwirut C, Sara VR, Nordberg A.

Neuroreport. 1993 Sep;4(9):1111-4.

PMID:
8219036
4.

Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics.

Slieker LJ, Brooke GS, Chance RE, Fan L, Hoffmann JA, Howey DC, Long HB, Mayer J, Shields JE, Sundell KL, et al.

Adv Exp Med Biol. 1993;343:25-32. Review. No abstract available.

PMID:
8184740
5.

The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.

Alexi T, Hughes PE, van Roon-Mom WM, Faull RL, Williams CE, Clark RG, Gluckman PD.

Exp Neurol. 1999 Sep;159(1):84-97.

PMID:
10486177
6.

[Insulin-like growth factor-I controls animal growth].

Takahashi SI, Takenaka A, Noguchi T.

Tanpakushitsu Kakusan Koso. 1996 Mar;41(3):267-80. Review. Japanese. No abstract available.

PMID:
8720781
7.

Three-dimensional solution structure of a disulfide bond isomer of the human insulin-like growth factor-I.

Sato A, Koyama S, Yamada H, Suzuki S, Tamura K, Kobayashi M, Niwa M, Yasuda T, Kyogoku Y, Kobayashi Y.

J Pept Res. 2000 Oct;56(4):218-30.

PMID:
11083061
8.

Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions.

Lowman HB, Chen YM, Skelton NJ, Mortensen DL, Tomlinson EE, Sadick MD, Robinson IC, Clark RG.

Biochemistry. 1998 Jun 23;37(25):8870-8.

PMID:
9636028
9.
10.
11.

Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro.

Saura J, Curatolo L, Williams CE, Gatti S, Benatti L, Peeters C, Guan J, Dragunow M, Post C, Faull RL, Gluckman PD, Skinner SJ.

Neuroreport. 1999 Jan 18;10(1):161-4.

PMID:
10094155
12.

Role of native disulfide bonds in the structure and activity of insulin-like growth factor 1: genetic models of protein-folding intermediates.

Narhi LO, Hua QX, Arakawa T, Fox GM, Tsai L, Rosenfeld R, Holst P, Miller JA, Weiss MA.

Biochemistry. 1993 May 18;32(19):5214-21.

PMID:
8494898
14.
15.

Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I.

Li YM, Arkins S, McCusker RH Jr, Donovan SM, Liu Q, Jayaraman S, Dantzer R, Kelley KW.

J Immunol. 1996 Jan 1;156(1):64-72.

PMID:
8598495
16.
17.

Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor.

Gauguin L, Klaproth B, Sajid W, Andersen AS, McNeil KA, Forbes BE, De Meyts P.

J Biol Chem. 2008 Feb 1;283(5):2604-13. Epub 2007 Nov 29.

18.

Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat.

Baker AM, Batchelor DC, Thomas GB, Wen JY, Rafiee M, Lin H, Guan J.

Neuropeptides. 2005 Apr;39(2):81-7. Epub 2005 Jan 28.

PMID:
15752541
19.

Engineering the C-region of human insulin-like growth factor-1: implications for receptor binding.

Gill R, Wallach B, Verma C, Ursø B, De Wolf E, Grötzinger J, Murray-Rust J, Pitts J, Wollmer A, De Meyts P, Wood S.

Protein Eng. 1996 Nov;9(11):1011-9.

20.

Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis.

Wang J, Dai H, Yousaf N, Moussaif M, Deng Y, Boufelliga A, Swamy OR, Leone ME, Riedel H.

Mol Cell Biol. 1999 Sep;19(9):6217-28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk